2-aroyl-4-acyl paclitaxel (taxol) analogs
CA 2328771 A1 · Owner: Virginia Polytechnic Institute And State University · Inventors: Kingston, David George Ian; Jagtap, Prakash G.; Chordia, Mahendra Devichand
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
2-debenzoyl-4-deacetyl paclitaxel, antineoplastic analogs thereof and intermediates are taught, as well as the formation of the compound analogs , and intermediates. The compound analogs and intermediates may be used to form pharmaceutical compositions having anti-neoplastic activity. Further the , compound, analogs and intermediates may be used to treat cancer when applied in an effective amount by means such as a pharmaceutical composition.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 30, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 30, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 30, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.